Uloric
NDC Package 55154-5159-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Uloric is febuxostat is used to lower uric acid levels in people with gout. Marketed by Cardinal Health, this product is identified by NDC 55154-5159 and is authorized under FDA application NDA021856.

Identification & Billing

NDC Package Code
55154-5159-8
Package Description
900 TABLET in 1 BOTTLE, PLASTIC
Product Code
55154-5159
11-Digit Billing Format
55154515908

Clinical Specifications

Proprietary Name
Uloric
Dosage Form
-
Usage Information
Febuxostat is used to lower uric acid levels in people with gout. Febuxostat works by reducing the amount of uric acid made by the body. An increased uric acid level can cause gout. Because of the risk of very serious heart-related problems and stroke with febuxostat (see also Warning section), febuxostat should be used only after treatment with a medication called allopurinol did not work to lower your uric acid level, caused serious side effects, or is not recommended by your doctor. Febuxostat should be used only if you have symptoms caused by a high blood uric acid level.

Regulatory & Marketing

Labeler Name
Cardinal Health
FDA Application #
NDA021856
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-13-2009
End Marketing Date
08-31-2023
Listing Expiration
08-31-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-5159-8 identifies a specific commercial package of 900 tablet in 1 bottle, plastic of Uloric, labeled by Cardinal Health. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cardinal Health on February 13, 2009. The current certification is valid through August 31, 2023.

What are the primary indications for this medication?

Febuxostat is used to lower uric acid levels in people with gout. Febuxostat works by reducing the amount of uric acid made by the body. An increased uric acid level can cause gout. Because of the risk of very serious heart-related problems and stroke with febuxostat (see also Warning section), febuxostat should be used only after treatment with a medication called allopurinol did not work to lower your uric acid level, caused serious side effects, or is not recommended by your doctor. Febuxostat should be used only if you have symptoms caused by a high blood uric acid level.

How is this Cardinal Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154515908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-5159-8
11-Digit CMS (5-4-2)
55154-5159-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.